Month: July 2014

FDA approves Eylea for DME

Another therapy has been approved for diabetic macular edema, one of the leading causes of vision loss in the United States…. FDA approves Eylea for DME Regeneron Pharmaceuticals, Inc. announced that the U.S. FDA has approved Eylea (aflibercept) for DME. Return to main website.

FDA OKs Ozurdex for Some With Diabetic Macular Edema

Another treatment for diabetic macular edema has been approved, providing us another option for patients who have had (or are about to have) cataract surgery. FDA OKs Ozurdex for Some With Diabetic Macular Edema Miriam E. Tucker The US Food and Drug Administration has approved […]